WASHINGTON, June 29 /PRNewswire-USNewswire/ -- Jim Kelly, who has been the President of the Food and Drug Law Institute for almost three years, announced today that he will not seek renewal of his contract so that he can pursue other opportunities closer to his family in the New York area. Mr. Kelly will remain as President of FDLI until a successor is named. In response to his announcement, William Schultz, Chairman of the Board of the FDLI, issued the following statement:
"On behalf of the Board of the Food and Drug Law Institute, I would like to commend Jim Kelly for his stewardship in ensuring the financial stability of FDLI and for his key role in developing the outstanding programs that the organization has held and the publications that it has issued during the past three years. We wish Jim the best of luck in his future endeavors and we know we can count on Jim to continue to help FDLI."
The Board will immediately begin a search for a new President. Anyone who is interested should contact Bill Schultz or Fred Degnan at one of the below numbers.
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.
Contacts: Bill Schultz, Chairman, FDLI Board of Directors, (202) 778-1820 Fred Degnan, Vice Chairman, FDLI Board of Directors, (202) 626-3742
|SOURCE Food and Drug Law Institute|
Copyright©2009 PR Newswire.
All rights reserved